September 12th, 2016
EpiPens Should Be Less Expensive
Kashif Shaikh, MD
This basic lifesaving medication is cheap to produce. It should not be a way to make a billion dollar profit. Should EpiPens be inexpensive and available? I say yes, and here are my reasons. I am not going to blame Shkreli or Bresch for trying to make money; it’s the system of silence and inaction that I blame. Money, power, corruption, and political influence are the […]
2021-2022 Chief Resident Panel
Abdullah Al-abcha, MD
Mikita Arora, MD
Madiha Khan, DO
Khalid A. Shalaby, MBBCh
Brandon Temte, DO
Resident chiefs in hospital, internal, and family medicine
Learn more about Insights on Residency Training.
NEJM Journal Watch – Recent General Medicine Articles- Correction: A Next-Generation Version of the Multitarget Stool DNA Test (Cologuard)
- Physician Empathy Is Associated Inversely with Chronic Pain Outcomes
- Long-Acting Octreotide Reduces Bleeding in Patients with Gastrointestinal Angiodysplasia
- Characteristics of Drug-Induced Liver Injury from Anabolic Steroids and Selective Androgen-Receptor Modulators
- Benefits of Comprehensive Primary Care for Persons Living with HIV